参考文献/References:
[1] Caliò A, Brunelli M, Segala D, et al. Angiomyolipoma of the kidney: from simple hamartoma to complex tumour. Pathology, 2021, 53(1):129-140.
[2] Jinzaki M, Silverman SG, Akita H, et al. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging, 2014, 39(3):588-604.
[3] Parmar N, Langdon J, Kaliannan K, et al. Wunderlich syndrome: wonder what it is. Curr Probl Diagn Radiol, 2022, 51(2):270-281.
[4] Restrepo JCA, Millan DAC, Sabogal CAR, et al. New trends and evidence for the management of renal angiomyolipoma: a comprehensive narrative review of the literature. J Kidney Cancer VHL, 2022, 9(1):33-41.
[5] 傅芬, 梁荣喜, 郑文婷, 等. 肾透明细胞癌与肾血管平滑肌脂肪瘤的超声造影表现及与微血管密度的相关性. 中国超声医学杂志, 2023, 39(6):676-679.
[6] Dipinto P, Canale V, Minelli R, et al. Qualitative and quantitative characteristics of CEUS for renal cell carcinoma and angiomyolipoma: a narrative review. J Ultrasound, 2024, 27(1):13-20.
[7] Zhu J, Li H, Ding L, et al. Imaging appearance of renal epithelioid angiomyolipoma: a case report and literature review. Medicine (Baltimore), 2018, 97(1):e9563.
[8] Hatano T, Egawa S. Renal angiomyolipoma with tuberous sclerosis complex: how it differs from sporadic angiomyolipoma in both management and care. Asian J Surg, 2020, 43(10):967-972.
[9] 林杉莎, 颜竹, 杜佳衡, 等. 基于CT影像特征鉴别小肾嫌色细胞癌及小乏脂型肾血管平滑肌脂肪瘤. 中国医学计算机成像杂志, 2024, 30(4):464-468.
[10] 林杉莎, 何晓鹏. 肾脏小乏脂血管平滑肌脂肪瘤的MSCT特征分析. 中国医学计算机成像杂志, 2024, 30(1):70-74.
[11] Yang JW, Liang C, Yang L. Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: a narrative review. Kaohsiung J Med Sci, 2022, 38(10):925-932.
[12] Park BK. Renal angiomyolipoma based on new classification: how to differentiate it from renal cell carcinoma. AJR Am J Roentgenol, 2019, 212(3):582-588.
[13] Li XL, Shi LX, Du QC, et al. Magnetic resonance imaging features of minimal-fat angiomyolipoma and causes of preoperative misdiagnosis. World J Clin Cases, 2020, 8(12):2502-2509.
[14] Cong X, Zhang J, Xu X, et al. Renal epithelioid angiomyolipoma: magnetic resonance imaging characteristics. Abdom Radiol (NY), 2018, 43(10):2756-2763.
[15] Thapa N, Maharjan S, Hona A, et al. Spontaneous rupture of renal angiomyolipoma and its management: a case report. Ann Med Surg (Lond), 2022, 79:104037.
[16] Ouzaid I, Autorino R, Fatica R, et al. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int, 2014, 114(3):412-417.
[17] Lee KH, Tsai HY, Kao YT, et al. Clinical behavior and management of three types of renal angiomyolipomas. J Formos Med Assoc, 2019, 118(1 Pt 1):162-169.
[18] Bhatt JR, Richard PO, Kim NS, et al. New trends natural history of renal angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy. Eur Urol, 2016, 70(1):85-90.
[19] Boorjian SA, Sheinin Y, Crispen PL, et al. Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology, 2008, 72(4):927-932.
[20] Liu Z, Zou Y, Lv T, et al. Spontaneous rupture of enormous renal angiomyolipoma in a pregnant tuberous sclerosis patient: a rare case. BMC Nephrol, 2020, 21(1):455.
[21] Qin C, Wang Y, Li P, et al. Super-selective artery embolization before laparoscopic partial nephrectomy in treating renal angiomyolipoma. Urol Int, 2017, 99(3):277-282.
[22] Fernández-Pello S, Hora M, Kuusk T, et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol, 2020, 3(1):57-72.
[23] 吕天石, 曹守金, 王健, 等. 介入治疗肾血管平滑肌脂肪瘤进展. 中国介入影像与治疗学, 2020, 17(12):755-758.
[24] Sw?rd J, Bohlin K, Henrikson O, et al. Long-term efficacy of selective arterial embolisation of renal angiomyolipoma. Scand J Urol, 2023, 58:86-92.
[25] Anis O, Rimon U, Ramon J, et al. Selective arterial embolization for large or symptomatic renal angiomyolipoma: 10 years of follow-up. Urology, 2020, 135:82-87.
[26] Lee S, Park HS, Hyun D, et al. Radiologic and clinical results of transarterial ethanol embolization for renal angiomyolipoma. Eur Radiol, 2021, 31(9):6568-6577.
[27] Rolland R, Loubet A, Bommart S, et al. Safety, efficacy and mid-term outcome for transarterial embolization (TAE) of renal angiomyolipoma (AML) using ethylene vinyl alcohol copolymer liquid embolic agent (EVOH). J Clin Med, 2023, 12(10):3385.
[28] Prigent FV, Guillen K, Comby PO, et al. Selective arterial embolization of renal angiomyolipomas with a N-butyl cyanoacrylate-lipiodol mixture: efficacy, safety, short- and mid-term outcomes. J Clin Med, 2021, 10(18):4062.
[29] Lyu T, Wang J, Tong X, et al. Efficacy and safety of CalliSpheres? Microsphere transcatheter-arterial chemoembolization versus conventional TACE in treating renal angiomyolipoma patients. J Cancer Res Ther, 2023, 19(4):933-938.
[30] Wang MQ, Duan F, Zhang H, et al. Comparison of polyvinyl alcohol versus combination of lipiodol-bleomycin emulsion and NBCA-lipiodol emulsion for renal angiomyolipoma embolization: a prospective randomized study. AJR Am J Roentgenol, 2023, 220(6):873-883.
[31] Gong M, Liu Z, Su H, et al. Urgent transcatheter arterial embolization for Wunderlich syndrome with hypovolemic shock secondary to ruptured renal angiomyolipoma. Front Surg, 2021, 8:704478.
[32] Villalta JD, Sorensen MD, Durack JC, et al. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol, 2011, 186(3):921-927.
[33] Li Z, Yang L, Yang H, et al. Comparison of superselective renal artery embolization versus retroperitoneal laparoscopic partial nephrectomy in ruptured hemorrhagic renal angiomyolipoma: a single-center study. Diseases, 2024, 12(9):218.
[34] Vaggers S, Rice P, Somani BK, et al. Evidence-based protocol-led management of renal angiomyolipoma: a review of literature. Turk J Urol, 2021, 47(Suppl 1):S9-S18.
[35] Castle SM, Gorbatiy V, Ekwenna O, et al. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery. BJU Int, 2012, 109(3):384-387.
[36] Liu F, Yuan H, Li X, et al. A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation. Ann Transl Med, 2019, 7(23):766.
[37] Ierardi AM, Petrillo M, Coppola A, et al. Percutaneous microwave ablation of renal angiomyolipomas in tuberous sclerosis complex to improve the quality of life: preliminary experience in an Italian center. Radiol Med, 2019, 124(3):176-183.
[38] Han ZY, Liang P, Yu XL, et al. Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: preliminary results. Acta Radiol, 2015, 56(1):56-62.
[39] Lin YT, Hung SW, Liu MC, et al. Feasibility of computed tomography-guided percutaneous renal cryoablation under local anesthesia: a single center experience in Taiwan. Anticancer Res, 2023, 43(4):1699-1708.(28/39)